Mergers: Commission clears the acquisition of LifeScan by Platinum
The European Commission has approved, under the EU Merger Regulation, the acquisition of control over LifeScan, Inc. by Platinum Equity, both of the US. LifeScan, currently part of Johnson&Johnson, provides blood glucose monitoring systems for home and hospital use under the global brand OneTouch. Platinum Equity is a private investment company, active in a wide range of businesses, including information technology, telecommunications, logistics, metal services, manufacturing and distribution. The Commission concluded that the proposed transaction would raise no competition concerns given the lack of horizontal overlaps and vertical relationships between the companies' activities. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.8887. (For more information: Ricardo Cardoso – Tel.: +32 229 80100; Maria Sarantopoulou - Tel.: +32 229 13740)
http://europa.eu/rapid/press-release_MEX-18-4065_en.htm
The European Commission has approved, under the EU Merger Regulation, the acquisition of control over LifeScan, Inc. by Platinum Equity, both of the US. LifeScan, currently part of Johnson&Johnson, provides blood glucose monitoring systems for home and hospital use under the global brand OneTouch. Platinum Equity is a private investment company, active in a wide range of businesses, including information technology, telecommunications, logistics, metal services, manufacturing and distribution. The Commission concluded that the proposed transaction would raise no competition concerns given the lack of horizontal overlaps and vertical relationships between the companies' activities. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.8887. (For more information: Ricardo Cardoso – Tel.: +32 229 80100; Maria Sarantopoulou - Tel.: +32 229 13740)
http://europa.eu/rapid/press-release_MEX-18-4065_en.htm
1
